⚕️ The information below is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Starting a GLP-1 receptor agonist — semaglutide (Ozempic, Wegovy, Rybelsus) or tirzepatide (Mounjaro) — is not a "take it and forget it" intervention. These medications affect multiple organ systems: kidneys, liver, pancreas, heart, and the endocrine system. Regular monitoring through blood tests and clinical assessments allows your doctor to confirm that the medication is working safely and that no early warning signs are being missed.
For Indian patients, the monitoring picture is complicated by several factors: widespread iron deficiency, high rates of vitamin B12 deficiency (especially in vegetarians), common thyroid disease, and the dual burden of diabetes and obesity that most GLP-1 users carry.
This guide tells you which tests to get, how often, what the results mean, and what approximate costs to expect at Indian diagnostic labs.
Consult your healthcare provider before starting any medication. This article is informational only — your doctor should determine your specific monitoring schedule.
Getting baseline values before starting is critical — without a baseline, you cannot know whether a changed value is caused by the medication or was pre-existing.
What it measures: Average blood glucose over the past 2–3 months Baseline importance: Establishes your starting glycaemic control Indian cost: ₹300–₹600 at SRL, Metropolis, Dr. Lal PathLabs Target on GLP-1: For type 2 diabetes — below 7% for most patients; below 6.5% if achievable without hypoglycaemia
What it measures: Blood sugar at two specific time points Indian cost: ₹150–₹300 total for both tests Note: HbA1c provides the trend; fasting glucose provides the daily snapshot. Both are needed.
What it measures: Serum creatinine, Blood Urea Nitrogen (BUN), eGFR (estimated glomerular filtration rate), urine protein/albumin-to-creatinine ratio Why critical: GLP-1 medications affect kidney haemodynamics and can reduce protein excretion in diabetic kidney disease (a good effect), but significant pre-existing kidney disease (eGFR below 30) requires dose adjustment or caution Indian cost: ₹500–₹900 for comprehensive renal panel Red flag: eGFR below 30 — discuss with your nephrologist before starting GLP-1 therapy
What it measures: ALT, AST, ALP, bilirubin, albumin Why critical: GLP-1 medications benefit non-alcoholic fatty liver disease (NAFLD) — now called metabolic dysfunction-associated steatotic liver disease (MASLD). However, if pre-existing liver disease is severe (cirrhosis), GLP-1 use requires specialist supervision Indian cost: ₹400–₹700
What it measures: Total cholesterol, LDL, HDL, triglycerides Why important: GLP-1 medications improve lipid profiles — documenting baseline allows you to demonstrate improvement over time Indian cost: ₹400–₹600
What it measures: TSH and thyroid hormone levels Why critical: (a) Hypothyroidism is extremely common in India and causes weight gain, fatigue, and hair loss — it can mimic GLP-1 side effects; (b) There is a theoretical concern about calcitonin and thyroid C-cell tumours (based on rodent data) — clinically, semaglutide and tirzepatide are not contraindicated in most thyroid conditions, but baseline documentation is important; (c) Thyroid disease must be controlled for GLP-1 to work optimally Indian cost: ₹400–₹700
What it measures: Haemoglobin, red blood cells, white blood cells, platelets Why important: Identifies pre-existing anaemia (extremely common in India, especially in women) — severe anaemia combined with GLP-1-induced food restriction can worsen without monitoring Indian cost: ₹200–₹400
What it measures: Iron stores in the body (more accurate than serum iron alone) Why critical: Ferritin is the best single marker for iron deficiency. Iron deficiency causes fatigue (mimicking GLP-1 adaptation), hair loss, and poor exercise tolerance — all of which will be wrongly attributed to the medication if iron deficiency is not identified Indian cost: ₹600–₹900 Optimal range: 50–150 ng/mL for people on calorie-restricted diets
What it measures: Serum vitamin B12 levels Why critical: (a) B12 deficiency is extraordinarily common in Indian vegetarians; (b) If the patient is also on metformin (very common in India for diabetes), metformin impairs B12 absorption — this is additive with GLP-1-induced reduced food intake Indian cost: ₹500–₹800 Alert level: Below 200 pg/mL — supplementation strongly indicated; below 150 pg/mL — neurological risk
What it measures: Vitamin D status Why important: India has paradoxically high rates of Vitamin D deficiency despite abundant sunlight. Deficiency causes fatigue, bone pain, and muscle weakness — all overlapping with GLP-1 adaptation symptoms Indian cost: ₹800–₹1,200 Optimal: Above 40 ng/mL for metabolic health; above 30 ng/mL minimum
| Test | At Start | Month 3 | Month 6 | Month 12 | Annually |
|---|---|---|---|---|---|
| HbA1c | ✓ (baseline) | ✓ | ✓ | ✓ | ✓ |
| Fasting glucose | ✓ | ✓ | ✓ | ✓ | ✓ |
| Kidney function (KFT + urine ACR) | ✓ | — | ✓ | ✓ | ✓ |
| Liver function (LFT) | ✓ | — | ✓ | ✓ | ✓ |
| Lipid profile | ✓ | — | ✓ | ✓ | ✓ |
| Thyroid (TSH) | ✓ | — | — | ✓ | ✓ |
| CBC (haemoglobin) | ✓ | ✓ | ✓ | ✓ | ✓ |
| Serum ferritin | ✓ | ✓ | ✓ | ✓ | ✓ |
| Vitamin B12 | ✓ | — | ✓ | ✓ | ✓ |
| Vitamin D | ✓ | — | ✓ | ✓ | ✓ |
| Amylase/Lipase (if symptoms) | Only if abdominal pain occurs |
GLP-1 medications can cause an initial decrease in eGFR of 5–10% in the first few months — this is usually not harmful and often reverses. However, watch for:
Routine measurement of amylase and lipase is NOT recommended as a screening test — many GLP-1 users have mildly elevated levels without pancreatitis. These tests should only be done if you develop:
Sudden severe abdominal pain on GLP-1 medications is a red flag — go to hospital immediately.
Most patients on GLP-1 medications see a 1–2% reduction in HbA1c within the first 3 months. If there is no improvement after 6 months at the target dose, discuss with your doctor whether dose adjustment or medication change is needed.
GLP-1 medications typically:
Blood tests alone do not capture whether the weight you are losing is fat or muscle. Body composition monitoring is an important adjunct:
Bioelectrical Impedance Analysis (BIA): Available on smart scales (Xiaomi Mi, Omron — ₹1,500–₹3,000) and at most gyms. Measures fat mass, muscle mass, and body water. Do at baseline, 3 months, 6 months.
DEXA Scan: Gold standard. Available at Apollo, Max, Fortis in metro cities. ₹2,500–₹5,000. Ideal at baseline and every 6–12 months.
Waist circumference: The most practical office measurement. Measure monthly with a cloth tape. Target for Indian men: below 90 cm; Indian women: below 80 cm.
Most Indian labs offer bundled packages that are significantly cheaper than individual tests:
Practical tip: Book tests early morning, fasting for 10–12 hours (for glucose and lipid panels). Drink water freely during the fast — dehydration falsely concentrates values.
Q: My doctor did not order any monitoring tests. Is that normal?
Unfortunately, in India, follow-up monitoring for GLP-1 medications is inconsistent — many patients receive their prescription without a structured monitoring plan. Proactively asking your doctor for a monitoring schedule is appropriate and important. If your doctor is unfamiliar with GLP-1 monitoring, seeking a second opinion from a diabetologist or endocrinologist is worthwhile.
Q: How do I interpret my eGFR on GLP-1 medications?
An eGFR above 60 mL/min/1.73m² is generally considered adequate for GLP-1 use. Between 30 and 60 (Stage 3 chronic kidney disease), GLP-1 medications can often still be used with closer monitoring. Below 30 (Stage 4–5 CKD), specialist input is required before using or continuing GLP-1 therapy.
Q: Should I stop GLP-1 medications before surgery or a procedure?
Yes — standard guidance recommends withholding weekly GLP-1 medications (Ozempic, Mounjaro) for at least 1 week before any procedure requiring general anaesthesia, due to increased aspiration risk from delayed gastric emptying. Daily injectables (Saxenda) — withhold on the day of procedure. Inform your anaesthetist that you are on a GLP-1 medication.
Consult your healthcare provider for a personalised monitoring schedule. This guide is informational — specific intervals and targets should be determined by your doctor based on your individual clinical profile.
